Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04273724 · ClinicalTrials.gov registry record · NA
Early Intervention for Impairments Identified During Comprehensive Geriatric Assessment in Patients With Bladder Cancer
A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04273724: Clinical Trial NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT04273724 is a NA study that was terminated before completion, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04273724, a NA study, was terminated before completion, sponsored by UNC Lineberger Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
A Comprehensive Geriatric Assessment (CGA) is a set of tests used to evaluate a patient's medical, social, and functional status, and can identify impairments in these domains that may not be noticed otherwise. Prior studies have shown that a CGA can accurately predict which patients are more likely to have serious side effects from cancer treatment. However, it is unknown whether interventions can be done to address the impairments found during a CGA in order to reduce the risk of these side effects. This pilot study will test the feasibility of targeted interventions for deficits identified during a CGA in patients 65 years or older with bladder cancer that have not yet started treatment.
Primary Outcome
To establish patient interest in referral for interventions based on impairments found during geriatric assessment within an outpatient genitourinary oncology clinic. Success will be at least 75% of patients accepting referral for indicated interventions.
Interventions
- OTHER Targeted Interventions for Impairments Identified During Geriatric Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-01-21 |
| Est. Completion | 2021-09-29 |
| Phase | NA |
Why NCT04273724 stopped before completion
NCT04273724 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Targeted Interventions for Impairments Identified During Geriatric Assessment is the first listed.
NCT04273724 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04273724 about?
NCT04273724 is a clinical study titled "Early Intervention for Impairments Identified During Comprehensive Geriatric Assessment in Patients With Bladder Cancer". A Comprehensive Geriatric Assessment (CGA) is a set of tests used to evaluate a patient's medical, social, and functional status, and can identify impairments in these domains that may not be noticed otherwise. Prior studies have shown that a CGA can accurately predict which patients are more likely...
What is the current status of trial NCT04273724?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2020-01-21. Estimated completion is 2021-09-29.
What interventions are being tested in trial NCT04273724?
The interventions under investigation include: Targeted Interventions for Impairments Identified During Geriatric Assessment (OTHER).
Who is sponsoring clinical trial NCT04273724?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04273724's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI